Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: Sunil S Dhawan, Jennifer Gwazdauskas
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W76278028
